Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115183) titled 'A single-arm, Phase II clinical trial study of HAIC-GEMOX in combination with immunotherapy and targeted therapy in intrahepatic cholangiocarcinoma with lymph node metastases' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Condition:
intrahepatic cholangiocarcinoma
Intervention:
Experimental group:HAIC-GEMOX+Immunotherapy+Targeted Therapy
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2025-12-23
Target Sample Size: Experimental group:30;Experimental group:30;
Countries of Recr...